Sign up to save your podcasts
Or
Share Icon boosts bioanalytical presence through Prevalere buy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Icon boosts bioanalytical presence through Prevalere buy
Icon's recent $43.2m acquisition of New York-based Prevalere Life Sciences is the latest part of the firm's expansion in the US CRO market. Outsourcing-Pharma spoke with Icon's VP of bioanalytical development, Brian O'Dwyer, and Prevalere CEO Mario Rocci from a busy AAPS conference in Atlanta.
View all episodes
By William Reed LtdIcon's recent $43.2m acquisition of New York-based Prevalere Life Sciences is the latest part of the firm's expansion in the US CRO market. Outsourcing-Pharma spoke with Icon's VP of bioanalytical development, Brian O'Dwyer, and Prevalere CEO Mario Rocci from a busy AAPS conference in Atlanta.